Alexander Agudelo

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Silver - Individuals

Equally adept at obtaining, litigating and monetising patents, OlarteMoure is an essential ally throughout the business lifecycle. At the partner and associate level, it has professionals with dual legal and scientific backgrounds, giving it an ideal toolkit for holistic problem solving. It engages in this throughout Latin America and is entrusted with regional portfolios by major players in the pharmaceutical industry such as Novartis, for which it has been successful in accelerating prosecution in the region using Patent Prosecution Highways. Spearheading campaigns and initiatives for Novartis, alongside Merck & Co, GlaxoSmithKline, Pfizer and Bristol Myers Squibb are Alexander Agudelo and Carlos Olarte, two partners around whom the practice revolves. As patent director, Agudelo keeps a cross-disciplinary team of 40 legal and technical professionals and paralegals well drilled. Cross-border patent protection and enforcement work is his forte. Olarte is the director of innovation, protection and technology transfer and has developed an excellent international reputation as a strategist. Before attending law school in the United States, he obtained a degree in biomedical and mechanical engineering. Joining his colleagues in the listings this year, Carlos Parra produces sterling results across the contentious/non-contentious divide for Colombian companies, universities, and research and development institutions. His unique selling points include concentrated licensing and IP commercialisation expertise and excellent connections in Japan, where he has worked previously – he leads the firm’s office in Tokyo.

Get unlimited access to all IAM content